Novo Nordisk Seeks To Block Sale Of Exubera, Claims Patent Infringement

 
• By Jessica Merrill

The insulin maker says Pfizer's Exubera infringes Novo's patents covering inhaled insulin.

More from Archive

More from Pink Sheet